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Signaling cascades during adipogenesis culminate
in the expression of two essential adipogenic factors,
PPARg and C/EBPa. Here we demonstrate that the
IRE1a-XBP1 pathway, the most conserved branch
of the unfolded protein response (UPR), is indispens-
able for adipogenesis. Indeed, XBP1-deficient
mouse embryonic fibroblasts and 3T3-L1 cells with
XBP1 or IRE1a knockdown exhibit profound defects
in adipogenesis. Intriguingly, C/EBPb, a key early
adipogenic factor, induces Xbp1 expression by
directly binding to its proximal promoter region.
Subsequently, XBP1 binds to the promoter of Cebpa
and activates its gene expression. The posttranscrip-
tional splicing of Xbp1mRNA by IRE1a is required as
only the spliced form of XBP1 (XBP1s) rescues the
adipogenic defect exhibited by XBP1-deficient cells.
Taken together, our data show that the IRE1a-XBP1
pathway plays a key role in adipocyte differentiation
by acting as a critical regulator of the morphological
and functional transformations during adipogenesis.
INTRODUCTION
Excess adipose tissue mass plays a central role in obesity-
related complications such as cancer, cardiovascular diseases,
insulin resistance, and type 2 diabetes. A comprehensive under-
standing of the molecular mechanisms underlying adipocyte
formation and development is of both fundamental and clinical
relevance. Cellular models, such as 3T3-L1 and mouse embry-
onic fibroblasts (MEFs), are invaluable in studying adipocyte
differentiation or adipogenesis (Farmer, 2006). During adipogen-
esis, two transcription factors, CCAAT/enhancer-binding protein
b (C/EBPb) and C/EBPd, are induced very early and play a crucial
role in initiating the differentiation program by activating the
expression of peroxisome proliferator-activated receptor g
(PPARg) and C/EBPa, two key adipogenic transcription factors
that positively regulate each other to promote and maintain the556 Cell Metabolism 9, 556–564, June 3, 2009 ª2009 Elsevier Inc.differentiated state (Farmer, 2006; Tontonoz and Spiegelman,
2008). Ectopic expression of either PPARg or C/EBPa induces
nonadipogenic fibroblasts to differentiate into adipocytes. Cells
or adipose tissues with disruption in either gene exhibit severe
defects in adipocyte differentiation or fat depot formation
(Farmer, 2006; Tontonoz and Spiegelman, 2008).
Under the regulation of this complex transcriptional circuit,
preadipocytes undergo dramatic transformations that ultimately
lead to terminal adipogenic differentiation. However, it remains
unclear how cells adapt to such dramatic morphological
changes. Given their endocrine capacity and unique cellular
structure, it has recently been hypothesized that adipocytes
may display elevated UPR in an attempt to alleviate stress in
the endoplasmic reticulum (ER) caused by increased protein
and lipid biosynthesis (Gregor and Hotamisligil, 2007). In yeast,
upon ER stress, ER-resident transmembrane protein IRE1a oli-
gomerizes and undergoes transautophosphorylation, leading
to activation of its cytosolic endoribonuclease domain (Cox
et al., 1993; Mori et al., 1993; Ron and Walter, 2007). Although
phosphorylation of IRE1a has been used widely as an activation
marker in experiments using ER stress inducers such as DTT or
thapsigargin (Tg), recent studies in yeast suggest that the kinase
activity may not be required for the endoribonuclease activity of
IRE1a (Papa et al., 2003; Korennykh et al., 2009). However, the
mechanism by whichmammalian IRE1a is activated under phys-
iological stress conditions remains largely unexplored.
Once activated, mammalian IRE1a splices 26 nucleotides
from the Xbp1mRNA, leading to a frameshift and the generation
of an active b-ZIP transcription factor, XBP1s, that contains a
C-terminal transactivation domain absent from the unspliced
form XBP1u. XBP1s subsequently translocates to the nucleus
and activates transcription of genes involved in protein folding
and degradation to restore ER homeostasis (Ron and Walter,
2007). Studies in animal models have revealed that the IRE1a-
XBP1 pathway is essential for the development and function of
the liver and heart as well as professional secretory cells such
as pancreatic exocrine and plasma cells (Masaki et al., 1999;
Reimold et al., 2000, 2001; Lee et al., 2005; Zhang et al.,
2005). Recently, XBP1 has been shown to regulate hepatic lipo-
genesis via a UPR-independent manner (Lee et al., 2008a).
However, its role in other cell types remains unclear.
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IRE1a-XBP1 in AdipogenesisInterestingly, XBP1 is highly expressed in embryonic adipose
depots (Clauss et al., 1993) and white adipose cells (Kajimura
et al., 2008). Moreover, XBP1/ neonates rescued with hepatic
XBP1s overexpression have no fat depot (Lee et al., 2005). These
findings prompted us to hypothesize that XBP1 plays a role in
adipocyte development. Indeed, our data demonstrate that
XBP1 controls adipogenesis in part by transactivating the
expression of a key adipogenic factor C/EBPa. In addition, our
results suggest that adipogenic differentiation is associated
with a low degree of UPR that is responsible for IRE1a activation
and the subsequent splicing of Xbp1 mRNA. Intriguingly, IRE1a
activity peaks during early adipogenesis and does not involve
its hyperphosphorylation.
RESULTS
XBP1 Is Indispensable for Adipogenesis
In 3T3-L1 differentiating adipocytes, Xbp1 mRNA increased
significantly at day 2 (d2) and peaked around d4 (Figure 1A).
Consistently, XBP1s protein also peaked at d4 (Figure 1B); this
pattern strikingly resembles the induction of PPARg and
C/EBPa. To examine the role of XBP1 during adipogenesis,
we transduced 3T3-L1 cells with control retroviruses (CONi) or
with retroviruses encoding short hairpin RNAs against XBP1
(XBP1i). Lines #4 and #5 exhibited over 80% and 60% knock-
down efficiency, respectively, as tested by immunoblots of cells
treated with Tg (Figure 1C, top) and quantitative polymerase
chain reaction (Q-PCR) analysis of differentiating XBP1i cells
(Figure 1A). When these cells were cultured under adipogenic
conditions, XBP1i-expressing cells demonstrated greatly atten-
Figure 1. XBP1 Is Essential for Adipocyte Differentiation
(A) Q-PCR analysis showing total Xbp1 mRNA levels in 3T3-L1
CONi and XBP1i #4 during differentiation. Data normalized to d0
time point of 3T3-L1 CONi cells. Data are means ± SEM. *p <
0.05 using unpaired two-tailed Student’s t test comparing CONi
to XBP1i at the same time point.
(B) Immunoblots showing the levels of XBP1s and key adipogenic
markers (C/EBPb, C/EBPa, and PPARg) during adipogenesis.
3T3-L1 preadipocytes treated with 300 nM Tg for 4 hr was loaded
as a control. XBP1u (30 kDa) protein was not detectable. HSP90
and CREB, loading controls.
(C) Top: Immunoblots of XBP1s protein in wild-type MEFs stably
expressing CONi, XBP1i #4, #5, or both treated with 300 nM Tg
for 4 hr. CREB, a loading control. Bottom: Macroscopic pictures
of Oil Red-O staining of 3T3-L1 cells expressing CONi and
XBP1i #4 and #5 differentiated for 8 days (d8).
(D) Left: Macroscopic pictures of Oil Red-O staining of wild-type
(WT) and XBP1/ MEFs differentiated for 24 days (d24). Right:
Immunoblots of XBP1s protein in MEFs treated with 300 nM Tg
for 4 hr.
uated differentiation, indicating an impaired adipo-
genic program (Figure 1C, bottom). Similar observa-
tions were obtained in XBP1/ MEFs (Figure 1D).
Arguing against a nonspecific effect provoked by
short interference RNAs, 3T3-L1 cells expressing
XBP1i that failed to effectively knock down
XBP1 (#1-2) exhibited no defects in adipogenesis
(Figure S1B, available online). Taken together, XBP1 is essential
for adipogenesis.
C/EBPb Induces Xbp1 Expression
In light of a significant induction of Xbp1 mRNA during early
differentiation, we next examined the mechanism underlying
the transcriptional regulation of Xbp1. We first tested which
component(s) of the adipogenic-inducing regimen was respon-
sible for regulating Xbp1 induction. Only isobutylmethylxanthine
(IBMX) or all three components of the regimen (IBMX, dexameth-
asone [DXM], and insulin) increased Xbp1 gene expression
(Figure 2A), suggesting that Xbp1 transcription is responsive to
changes in cellular cAMP levels, as IBMX is a phosphodiesterase
inhibitor.
The ability of cAMP signals to activate C/EBPb during adipo-
genesis (Cao et al., 1991; Farmer, 2006) prompted us to test
whether C/EBPb regulates Xbp1 expression. Indeed, total
Xbp1mRNA increased nearly 10-fold with a peak at 8 hr postin-
duction within the first 24 hr; this upregulation occurred subse-
quently to that of the Cebpb gene, which peaked at 2 hr postin-
duction (Figure 2B). Consistently, XBP1s protein levels also
peaked at 8 hr postinduction (Figure 2C).
Supporting the scenario that C/EBPb directly regulates Xbp1
expression, recent genome-wide analysis identified putative
C/EBP binding sites on the Xbp1 promoter (Lefterova et al.,
2008). Indeed, sequence analysis of mammalian Xbp1 proximal
promoter revealed the presence of a highly conserved C/EBP
binding element (Osada et al., 1996) centered at482 bp relative
to transcription start site (Figure S2A). Chromatin immunoprecip-
itation (ChIP) experiments showed enrichment of C/EBPbCell Metabolism 9, 556–564, June 3, 2009 ª2009 Elsevier Inc. 557
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and on d4 (Figure 2D). Further confirming the specificity of the
C/EBPb antisera, no signal was detected at the 30 untranslated
region of Xbp1 (not shown). In addition, overexpression of
Figure 2. C/EBPb Induces Xbp1 Expression
(A) Q-PCR analysis of Xbp1 mRNA in 3T3-L1 cells (d0) treated with various
stimuli as indicated for 8 hr. Data normalized to the mock-treated sample
(CON).
(B) Q-PCR analysis showing the expression patterns of Xbp1 and Cebpb
mRNA within the first 24 hr postinduction in differentiating 3T3-L1 cells.
(C) Immunoblot showing the expression patterns of XBP1s, CHOP10, and
C/EBPb proteins in differentiating 3T3-L1 cells. HSP90, a loading control.
(D) ChIP analysis showing the recovery of Xbp1 promoter from immunoprecip-
itates of C/EBPb or control IgG prepared from differentiated 3T3-L1 cells at d0,
8 hr postinduction, and d4. The amount of Xbp1 promoter (580 to 425 bp)
recovered was quantitated using Q-PCR. Data normalized to the IgG controls
at each point.
(E) Luciferase assay showing effects of C/EBPb on wild-type (WT) or mutated
Xbp1 reporter activity (689 to +37 bp) in HEK293T cells transiently trans-
fected with control GFP (CON) or C/EBPb. DC/EBP, deletion of the C/EBP
binding site (Figure S2B).
(F, G) Knockdown of C/EBPb reduces Xbp1 level. Western blot (F) showing the
protein level of C/EBPb in 3T3-L1 stably expressing CONi or C/EBPbi. Q-PCR
analysis (G) ofCebpb and Xbp1mRNA levels at 4 hr or 8 hr postinduction. Data
are represented asmean ± SEM. *p < 0.05 using unpaired two-tailed Student’s
t test comparing either the samples included by the brackets or that particular
sample to the rest samples.558 Cell Metabolism 9, 556–564, June 3, 2009 ª2009 Elsevier Inc.C/EBPb in HEK293T cells activated a Xbp1 promoter (689 to
+37 bp)-luciferase reporter (Figure 2E). This activation was
significantly attenuated over 50% by deleting the putative
binding element (Figures S2B and 2E).
To further confirm the effect of C/EBPb on Xbp1 induction, we
generated 3T3-L1 cells stably expressing C/EBPb shRNA with
over 80% knockdown efficacy (Figures 2F–2G). Loss of
C/EBPb significantly blocked differentiation as expected
(Figure S2C). Indeed, Xbp1mRNA levels were reduced by nearly
60% in differentiating C/EBPbi 3T3-L1 cells comparedwith CONi
cells at 8 hr postinduction (Figure 2G). Taken together, our data
strongly suggest that the Xbp1 gene is a bona fide direct target of
C/EBPb during adipogenesis.
Adipogenesis Is Associated with a Low Measure of UPR
IRE1a is the predominant form of IRE1 in adipocytes (not shown),
and throughout adipogenesis its mRNA expression level did not
vary significantly (Figure S3A). During UPR, IRE1a splices Xbp1
mRNA to generate XBP1s, a potent transcription factor (Ron
and Walter, 2007). Phosphorylation of IRE1a and Xbp1 mRNA
splicing are two common markers of UPR activation that can
be assessed by the mobility shift of IRE1a protein on an SDS-
PAGE gel and by the ratio of the spliced Xbp1s mRNA to total
Xbp1mRNA using reverse transcription PCR (RT-PCR) analysis,
respectively.
To increase the resolution of the phosphorylated forms of
a protein on a SDS-PAGE, we incorporated Phos-tag and
Mn2+ in regular SDS-PAGE gels (Kinoshita et al., 2006). Dramat-
ically, in HEK293T cells, nearly 100% of IRE1a proteins were
hyperphosphorylated upon a 1.5 hr treatment with Tg, and only
30% were hyperphosphorylated after 13 hr (Figure 3A). Inter-
estingly, in all the conditions and samples tested, IRE1a ex-
hibited one predominant band shift that was reversible by calf
intestine phosphatase (CIP) treatment (Figure 3B), suggesting
that transautophosphorylation of mammalian IRE1a may not
be as extensive as predicted for the yeast counterpart (Kore-
nnykh et al., 2009).
Surprisingly, we failed to observe a mobility shift of IRE1a at
any time point during differentiation (Figure 3B). Arguing against
the possibility that IRE1a in 3T3-L1 cells can not be phosphory-
lated, Tg treatment for as little as 20 min induced a dramatic
mobility shift of nearly 100% of IRE1a proteins (Figure 3A).
Consistently, the majority of IRE1a in both white and brown
adipose tissues (WAT and BAT) of wild-type lean animals at
23–27 weeks of age were not phosphorylated (Figures 3C and
S3B). In contrast, IRE1a phosphorylation was readily detectable
in the liver from the same set of mice (Figure S3B).
Next, we quantitated the percent of Xbp1 splicing using
RT-PCR as a direct measure of IRE1aRNase activity. Unexpect-
edly, Xbp1 mRNA splicing peaked at d0 (mean and standard
error of the mean [± SEM]; 55.9 ± 4.9%) and reached nadir at
d4 (15.1 ± 2.4%) (Figures 3D and S3C). Supporting the physio-
logical relevance of our cell model, the level of Xbp1 mRNA
splicing on d8 of 3T3-L1 adipocytes was very similar to that of
adipose tissues from wild-type lean mice (23.1 ± 4.1% versus
18.3 ± 1.3%, Figure 3E). As a positive control, Xbp1 mRNA
splicing reached approximately 50% in pancreas of lean wild-
type animals (Iwawaki et al., 2004 and not shown). Given that
d0 adipocytes and pancreas exhibit similar levels of Xbp1
Cell Metabolism
IRE1a-XBP1 in AdipogenesisFigure 3. Adipogenesis Is Associated with a Low Level of Physiological UPR
(A) Western blot showing mobility shift of IRE1a using Phos-tag or regular SDS-PAGE gels in (left) HEK293T and (right) 3T3-L1 cells treated with 300 nM Tg for
indicated period. ‘‘p’’ and ‘‘0,’’ hyper- and nonphosphorylated IRE1a, respectively. Solid and dotted lines on the left-hand side indicate Phos-tag and regular gels,
respectively.
(B) Immunoblot showing separation of p-IREa from IRE1a using regular and Phos-tag gels with or without CIP treatment (1 hr) in differentiating 3T3-L1 adipocytes.
Two positive controls: Tg1, HEK293T cells treated 300nM Tg for 1.5 hr; Tg 2, 3T3-L1 cells treated 300nM Tg for 4 hr. HSP90, a loading control.
(C) Western blot showing mobility shift of IRE1a in white adipose tissues (WAT) collected from wild-type lean and ob/ob animals using Phos-tag with or without
CIP treatment. The age of the mice (in weeks) shown.
(D–F) RT-PCR analysis of Xbp1 splicing (Xbp1u and s) in (D) differentiating 3T3-L1 adipocytes, (E) WAT of wild-type lean (wt) and obese animals, and (F) differ-
entiating 3T3-L1 andMEFs with XBP1 deficiency at d8 and d9, respectively. Samples treated with Tg for 2 hr or 5 hr were used as controls. L32, a loading control.
(G) Electron microscopic images of differentiated 3T3-L1 CONi or XBP1i adipocytes at d5. Each image taken from a different cell. Arrows, ER; m, mitochondrion;
N, nucleus; L, lipid droplets. Scale bar shown at the right corner of each panel.
(H) Macroscopic images of differentiation of 3T3-L1 expressing CONi or XBP1i plus pBabe-vector, XBP1s or XBP1u. Oil Red-O staining was carried out on d6.
(I–K) Knockdown of IRE1a reduces Xbp1 splicing and attenuates differentiation. Western blot analysis (I) showing the IRE1a and XBP1s protein levels in XBP1i
and IRE1ai #4 3T3-L1 cells. Nuclear-extracts were used for blots showing the levels of XBP1s in cells treated with 300 nM Tg for 3 hr. HSP90 and CREB, loading
controls. (J) RT-PCR analysis of Xbp1 splicing (Xbp1u and s) in 3T3-L1 cells treated with Tg for 3 hr and quantitated as above. (K) Macroscopic images of differ-
entiation of 3T3-L1 expressing CONi, XBP1i, C/EBPbI, or IRE1ai#4. Oil Red-O staining was carried out on d10. For RT-PCR analysis of Xbp1 splicing, quantifi-
cation was done using the NIH ImageJ software where band densities was calculated and subtracted from the background. Data are represented asmean ± SEM
of data from at least three experiments. *p < 0.05 using unpaired two-tailed Student’s t test comparing the samples included by the brackets.mRNA splicing, we conclude that physiological UPR is activated
during early adipogenesis.
Obesity is postulated to cause ER stress or UPR in adipose
tissues. However, the nature and the extent of UPR in adipose
tissues of obese animals remain unclear. To this end, we exam-
ined IRE1a phosphorylation and Xbp1 splicing in mice thatwere induced to become obese either genetically or with diet
(ob/ob and HFD). Unexpectedly, 15% of IRE1a proteins
were phosphorylated in WAT of these animals (Figure 3C and
not shown). Correspondingly, the splicing of Xbp1 in WAT
was increased from 18.3 ± 1.3% in lean mice to 33.9 ± 6.8%
in obese animals (Figures 3E and S3D). Thus, our data supportCell Metabolism 9, 556–564, June 3, 2009 ª2009 Elsevier Inc. 559
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obesity.
During differentiation, XBP1s protein levels were inversely
correlated with Xbp1s mRNA levels (Figure 1B versus 3D and
2C versus S3C). We reasoned that XBP1 may function to main-
tain UPR in adipocytes at a low level via feedback inhibition on
UPR and IRE1a activity. To directly test this possibility, we
measured Xbp1 mRNA splicing in XBP1-deficient cells and
wild-type cells. Indeed, Xbp1 mRNA splicing was increased
over 2-fold in XBP1i versus CONi adipocytes on d8 (48.6 ±
1.1% versus 21.9 ± 3.3%, Figure 3F). Similar observations
were obtained in XBP1/ differentiatingMEF adipocytes (26.1 ±
3.9% versus 14.6 ± 1.8%, Figure 3F). Surprisingly, themajority of
IRE1a was not hyperphosphorylated in XBP1-deficient adipo-
cytes (Figure S3E).
Because UPR is intimately linked to ER morphology and func-
tion (Ron and Walter, 2007), we examined the fine structure of
the ER using transmission electron microscopy. Unlike the
packed ER cisternae characteristic of professional secretory
cells (Harding et al., 2001; Lee et al., 2005), the ER of adipocytes
(d5) have few loosely dispersed cisternae with discernible ribo-
somes (Figure 3G) as shown previously (Novikoff et al., 1980).
By contrast, most of the ER in the XBP1i cells were fragmented
and somewhat dilated compared with those in control adipo-
cytes (Figures 3G and S3I). Thus, our data suggest that XBP1
functions to maintain ER homeostasis in adipocytes; hence
loss of XBP1 in adipocytes disrupts ER function and activates
IRE1a.
To determine if the IRE1a-mediated splicing event is critical for
differentiation, we transduced 3T3-L1 XBP1i cells with retrovi-
ruses encoding the pBabe vector, XBP1u or XBP1s
(Figure S3F). Only ectopic expression of XBP1s almost
completely rescued the differentiation defect of 3T3-L1 XBP1i
cells (Figure 3H). Further supporting the role of XBP1s in adipo-
genesis, XBP1s protein levels were much higher than XBP1u in
differentiated 3T3-L1 cells at d6 (Figure S3G). Thus, Xbp1
mRNA splicing by IRE1aRNase activity is required for adipogen-
esis.
To directly test the consequences of IRE1a deficiency in adi-
pogenesis, we generated 3T3-L1 cells stably expressing IRE1a
shRNA (IRE1ai). One shRNA (#4) reduced IRE1a protein levels
to less than 10% of controls (Figure 3I). Supporting a key role
of IRE1a in mediating Xbp1 splicing, knockdown of IRE1a signif-
icantly reduced Xbp1 splicing (54.4 ± 2.2% CONi, 41.7 ± 6.7%
XBP1i versus 24.3 ± 3.6% IRE1ai, Figure 3J) and XBP1s produc-
tion in cells treated with Tg for 3 hr (Figure 3I). Cells stably ex-
pressing IRE1ai#4 failed to undergo differentiation to a similar
degree as XBP1i or C/EBPbi cells (Figure 3K); cells expressing
shRNA (#2) with no knockdown effect exhibited normal differen-
tiation (Figure S3H). Thus, our data indicate that adipogenic
conversion is associated with UPR and the IRE1a-XBP1 branch
is indispensable for adipogenesis.
XBP1 Directly Regulates C/EBPa Expression
We speculated that XBP1 may regulate the expression of an
important adipogenic factor. Indeed, C/EBPa protein levels
were significantly decreased in differentiating XBP1/ MEFs
while C/EBPb levels remained largely unaffected (Figure 4A).
Similar observations were obtained in 3T3-L1 adipocytes560 Cell Metabolism 9, 556–564, June 3, 2009 ª2009 Elsevier Inc.(Figure S4A). Furthermore, Cebpa mRNA levels on both d4 and
d6 were significantly reduced by over 90% in 3T3-L1 XBP1i cells
compared with CONi cells whereas both Pparg1 and 2 mRNA
levels were reduced by approximately 50% only on d6
(Figure 4B). Supporting the notion that XBP1 targets are cell-
type specific (Lee et al., 2005; Acosta-Alvear et al., 2007),
expression of some known XBP1 targets Erdj4 and p58IPK
(Lee et al., 2003) was not affected in XBP1i adipocytes
(Figure 4B).
XBP1 preferentially binds to CRE-like sequences containing
an ACGT core (Clauss et al., 1996; Acosta-Alvear et al., 2007).
Considering that the Cebpa proximal promoter region contains
a highly conserved putative XBP1 binding element centered at
270 bp (Figure 4C), we tested the role of XBP1 in modulating
Cebpa expression in adipocytes. Pointing to a direct regulatory
role for XBP1 in vivo, XBP1was enriched on theCebpa promoter
on d4 (Figure 4D); this binding was comparable with that of
C/EBPb on d4 and was completely abolished in XBP1i 3T3-L1
cells (Figures 4D and S4B). Demonstrating the specificity of the
antibody, the XBP1 antibody is highly specific for both XBP1s
and XBP1u proteins in immunoprecipitation (Figure S4D).
In further support of the notion that XBP1 transactivates
Cebpa expression, XBP1s overexpression increased Cebpa
promoter activity in luciferase reporter assays in XBP1/
MEFs and HEK293T cells whereas XBP1u had no effect
(Figure S4E). The activity of XBP1s on the Cebpa promoter
was comparable with that on the promoter of a known target
gene Edem1 (Figure S4E); this activation was largely abolished
by either mutation or deletion of the XBP1 binding element on
the Cebpa promoter (Figures S4C and 4E). In a rescue experi-
ment, C/EBPa overexpression readily rescued the differentiation
defects observed in XBP1i cells (Figure S4F), suggesting that
adipogenic attenuation in these cells may be in part due to the
reduction in C/EBPa levels. Taken together, our data demon-
strate that Cebpa is a bona fide target of XBP1s in adipocytes.
DISCUSSION
Adipocytes are specialized cell types that integrate lipid metab-
olism with protein synthesis in a very compact cellular space.
Here we show that the IRE1a-XBP1 pathway, the most
conserved branch of the UPR, is indispensable for the cellular
transformation into adipocytes (Figure 4F). Investigation of the
underlying mechanism uncovered a number of discoveries
about the function of the IRE1a-XBP1 branch in adipogenesis
that increased our understanding of this pathway in adipocytes.
First, we show that adipogenesis is associated with a low level
of UPR—termed ‘‘physiological’’ UPR. IRE1a activity peaks
during early adipogenesis with nearly 55% of Xbp1mRNA being
spliced. Subsequently, splicing is reduced to 10%–20% in
mature adipocytes. Indeed, the splicing in fully differentiated
adipocytes in our culture system is equivalent to that in mature
adipocytes from wild-type lean mice. Upon induction of obesity,
there is approximately a 2-fold increase in Xbp1 mRNA splicing
with only aminor fraction of the IRE1a proteins being hyperphos-
phorylated. In support of our observations, UPR activation was
detected mainly in the pancreas and skeletal muscles in
a UPR-reporter transgenic mouse model with 50% and 26%
Xbp1 mRNA splicing, respectively; no UPR was detected in
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IRE1a-XBP1 in AdipogenesisFigure 4. XBP1 Controls Cebpa Expression
(A) Western blot analysis of C/EBPa and C/EBPb protein levels in XBP1/ and wild-type MEFs. GRP78 and GAPDH, loading controls.
(B) Q-PCR analysis in differentiating 3T3-L1 expressing CONi and XBP1i #4. Data normalized to d0 time point of 3T3-L1 CONi adipocytes.
(C) Conservation of XBP1 binding sites on the Cebpa promoter. The core binding element ACGT is underlined.
(D) ChIP analysis showing the recovery of Cebpa promoter from immunoprecipitates of C/EBPb, XBP1, or control IgG prepared from 3T3-L1 cells at d0, 8 hr
postinduction and d4 as indicated. The amount of Cebpa promoter (335 to 82 bp) recovered was quantitated using Q-PCR. Data normalized to the IgG
controls at each point.
(E) Luciferase assay showing effects of XBP1s on Cebpa reporter activity (320 to +45 bp) in HEK293T cells transiently transfected with control GFP (CON) and
XBP1s. The Cebpa reporter constructs with either mutation (XBPmt) or deletion (DXBP) of the XBP1 binding sites were included. Data represented as mean ±
SEM. *p < 0.05 using unpaired two-tailed Student’s t test comparing the samples included by the brackets.
(F) Model showing the role of IRE1a-XBP1 in adipogenesis. The new findings described in this paper are highlighted in bold. See text for details.any other organs including adipose tissues (Iwawaki et al., 2004).
Thus, we conclude that UPR is activated at an early stage of adi-
pogenesis and maintained at a relatively low physiological level
in mature adipocytes. Moreover, obesity is associated with
elevated UPR, but the level of UPR activation incurred in adipose
tissues is not as high as anticipated.
Second,weshow that themajority of IRE1aproteins arenot hy-
perphosphorylated during adipogenesis even as Xbp1 mRNA
splicing approaches 55% on d0 of adipocyte differentiation. We
speculate that hyperphosphorylation may not be required for
activation of IRE1a RNase activity under physiological UPR.
Indeed, although several structural studies have implicated the
importance of dimerization and transautophosphorylation ofIRE1a in activation of its RNase activity (Zhou et al., 2006; Lee
et al., 2008b), an earlier study showed that the kinase-defective
IRE1a K599A mutant has intact RNase activity (Tirasophon
et al., 2000). Furthermore, a recent structural study on the cyto-
solic domain of yeast IRE1a (Korennykh et al., 2009) suggests
that transautophosphorylation of IRE1a is not required for its
RNase activation. Because our data show that IRE1a RNase
activity is dynamically regulated during adipogenesis, some
intriguing questions arise: Is IRE1a activated by misfolded
proteins during adipogenesis? How is IRE1a RNase activity
affected by transautophosphorylation during this process?
Does oligomerization of IRE1a proteins and formation of IRE1a
foci occur under physiological UPR in mammals as shown inCell Metabolism 9, 556–564, June 3, 2009 ª2009 Elsevier Inc. 561
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required before we can fully appreciate the mechanisms of
mammalian IRE1a activation under physiological conditions.
Third, we show that C/EBPb regulates Xbp1 expression, which
in turn modulates the expression of a key adipogenic factor
C/EBPa. Cells or animals lacking XBP1 have profound defects
in adipogenesis and adipose development (this study and Lee
et al., 2005), similar to the phenotypes of C/EBPa-deficient cells
or adipose tissues (Farmer, 2006; Tontonoz and Spiegelman,
2008). Because PPARg and C/EBPa are critical for the induction
and maintenance of each other, further studies are required to
determine whether regulation of Cebpa by XBP1 and PPARg
occurs independently or in concert. Additionally, generation of
adipose-specific IRE1a or XBP1 null animals will elucidate the
role of UPR in the pathogenesis of obesity and insulin resistance.
Fourth, we show that the IRE1a-XBP1 pathway of the UPR is
important for adipogenic differentiation. In light of the observa-
tions made in this study, it is interesting to compare the roles of
XBP1 in governing adipogenesis with that of myogenesis or
plasma cell differentiation. In myogenic differentiation, two key
myogenic factors, MyoD and myogenin, transactivate Xbp1
expression (Blais et al., 2005), which in turn transactivates
Mist1, a negative regulator of MyoD, leading to decreased differ-
entiation (Acosta-Alvear et al., 2007). During early B cell differen-
tiation, IRF4 andBlimp-1 regulateXbp1 expression (Shaffer et al.,
2004; Klein et al., 2006), which in turn induces the expression of
IL-6, a key growth factor for drivingBcell differentiation (Iwakoshi
et al., 2003). Thus, these results suggest that the IRE1a-XBP1
pathway may act as a critical regulatory component of diverse
cellular differentiation events. Further studies of the activation
of the different UPR components during adipocyte differentiation
and their mechanisms of action will clarify how preadipocytes
undergo their amazing transformation into adipocytes and will
provide insights into the nature of physiological UPR.
EXPERIEMENTAL PROCEDURES
Cells
3T3-L1 preadipocytes, XBP1/ and wild-type control MEFs (gifts from Laurie
Glimcher, Harvard Medical School), HEK293T, and phoenix cells were main-
tained in DMEM supplemented with 10% FBS (Hyclone). Tg (EMD Calbio-
chem) was used at 300 nM.
Retroviral Transduction and Stable Cell Line Generation
Phoenix cells were transfected with the plasmids encoding the gene of interest
in pSuper or pBabe vectors and VSVG at 2:1 ratio for 16 hr and then replaced
with fresh culturemedia. Following 48 hr culture, media containing retroviruses
were harvested and used to transduce target cells in the presence of 5 mg/ml
polybrene (Sigma) for 24 hr. Stable cell lines were selected in the presence of
2 mg/ml puromycin (Sigma) or 500 mg/ml G418 (EMD Calbiochem) and then
used for differentiation. Typically, puromycin-resistant cell lines developed in
6 days whereas G418-resistant cell lines were generated in 12 days. In rescue
experiments, 3T3-L1 cells transducedwith two retroviruseswere selected with
both puromycin and G418. Tominimize the batch-to-batch difference, we only
compared cells made from the same batch of cells.
shRNA Knockdown
Two vectors were used in this study: pSuper/retro (H1 promoter, a gift from
Lee Kraus, Cornell University) and pSuper/U6/retro (U6 promoter, described
in the Supplemental Experimental Procedures). XBP1i and IRE1ai were driven
by the U6 promoter, while the C/EBPbi was driven by the H1 promoter. Control562 Cell Metabolism 9, 556–564, June 3, 2009 ª2009 Elsevier Inc.RNAi were against the firefly luciferase or the GFP gene. Target sequences are
shown in Table S2.
Mice and Tissues
Wild-type and ob/ob mice on C57BL/6 background were purchased from the
Jackson Laboratory. The epididymal WAT, BAT, and liver were harvested from
(a) wild-type mice fed with either 60% HFD (Research Diets Inc.) or 10% chow
diet for over 13 weeks; (b) the ob/obmice at the age of 12–26 weeks. Tissues
were harvested immediately following cervical dislocation, snap-frozen in
liquid nitrogen, and stored at 80C (Qi et al., 2009). All animal procedures
were approved by the Cornell IACUC.
Plasmids and Viruses
XBP1u and XBP1s cDNAs, cloned from themouseWAT cDNA library using pfu
polymerase (Stratagene), were subcloned into pcDNA3/Flag or 3x HA vectors.
Retroviral encoding XBP1u and Flag-XBP1s were cloned by shuttling XBP1
cDNA into the pBabe-puro vector. For retroviral transduction in the 3T3-L1
experiments, cDNAs encoding the mouse C/EBPb and rat C/EBPa were
cloned into the pBabe-puro vector using standard PCR reactions. Promoter
regions of mouse Xbp1 (689 to +37 bp), Edem (336 to +15 bp), and Cebpa
(320 to +45 bp) were cloned via PCR of tail genomic DNA of C57BL/6 mice
and ligated into the pGL3-basic luciferase reporter construct (Promega).
Constructs generated by PCR were sequenced by the Cornell DNA
sequencing facility.
Adipogensis
(a) 3T3-L1: Two days postconfluency (d0), cells were treated for 48 hr with 0.25
mM IBMX, 1 mM DXM (EMD Calbiochem), and 1 mg/ml insulin (Sigma). After-
wards, cells were fed every 48 hr with 1 mg/ml insulin in culture media until
d8 postconfluence. (b) MEF: Cells were differentiated as 3T3-L1 with the
following modifications: when the cells became confluent (d0), they were
treated with 0.25mM IBMX, 5 mMDXM, 10 mg/ml insulin, and 5 mM troglitazone
(EMD Calbiochem) for the first 48 hr. Subsequently, cells were maintained in
1 mg/ml insulin and 5 mM troglitazone to induce terminal differentiation.
Oil Red-O Staining
Cells were fixed with 10% formaldehyde in PBS for 15 min at room tempera-
ture and stained with freshly prepared Oil Red-O working solution for 30 min
followed by three washes with water. Plates were scanned using an Epson
scanner. Oil Red-O working solution was prepared by mixing 6 ml 0.5% Oil
Red-O (Sigma) in isopropanol with 4 ml ddH2O followed by filtration through
a Whatman #1 filter paper (Millipore).
Western Blot
Western blot was performed using 15–30 mg total cell lysates or 10 mg nuclear
extracts. The following antibodies were used in this study: C/EBPb (mouse,
1:1000, Biolegend); GRP78 (goat, 1:1,000), C/EBPa (rabbit, 1:2,000), PPARg
(mouse, 1:400), XBP1 (rabbit, 1:1,000), and HSP90 (rabbit, 1:5,000) (Santa
Cruz); IRE1a (rabbit, 1:1,000, Cell Signaling); GAPDH (rabbit, 1:10,000, Novus
Biologicals). Secondary antibodies, goat anti-rabbit immunoglobin G (IgG),
anti-mouse IgG (Biorad), and donkey anti-goat IgG HRP (Jackson ImmunoR-
esearch), were used at 1:10,000. The p-Ser724 IRE1a antibody from Novus
Biologicals did not work in our hand.
Phos-tag Gels
Phos-tag gel was carried out the same way as regular western blots, except
that: (a) 5% SDS-PAGE containing 50 mM Phos-tag (NARD Institute) and 50
mM MnCl2 (Sigma) were used; (b) gels were soaked in 1 mM EDTA for 10
min before transfer onto a PVDF membrane.
RNA Extraction and Q-PCR
Total RNA was extracted using Trizol per the supplier’s protocol (Molecular
Research Center) and reverse transcribed using the Superscript III kit (Invitro-
gen). cDNA were analyzed using the Power SYBR Green PCR kit on the ABI
PRISM 7900HT Q-PCR machine (Applied Biosystems) or the SYBR Green
PCR system (gifts from Jeff Pleiss, Cornell University) on the iQ5 or Cfx384
Q-PCR machine (Bio-Rad). All Q-PCR data were normalized to ribosomal
l32 gene.
Cell Metabolism
IRE1a-XBP1 in AdipogenesisRT-PCR for Xbp1 Splicing
PCR primers were designed to encompass the splicing sequences of mouse
Xbp1 (Table S1). PCR products, amplified with annealing temperature at
58C for 30 cycles, were separated by electrophoresis on a 2.5% agarose
gel (Invitrogen). Quantitation of percent of splicing, defined as the ratio of
Xbp1s level to total Xbp1 (Xbp1u +Xbp1s) levels, was carried out using the
NIH ImageJ software.
Statistical Analysis
Results are expressed as mean ± SEM. Comparisons between groups were
made by unpaired two-tailed Student’s t test, where p < 0.05 was considered
as statistically significant. All experiments were repeated at least three times
and representative data are shown.
SUPPLEMENTAL DATA
The Supplemental Data include four figures, two tables, and Supplemental
Experimental Procedures, and can be found with this article online at http://
www.cell.com/cellmetabolism/supplemental/S1550-4131(09)00121-1.
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